Miami Rheumatology, LLC

Miami Rheumatology, LLC was paid $2.24M by Medicaid between Jan 2018 and Dec 2024, across 10 billing codes. Its largest line is J3262, Injection, tocilizumab, 1 mg — 80% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	256	$5K
2019	1,615	$218K
2020	2,070	$306K
2021	1,948	$75K
2022	1,918	$534K
2023	2,407	$790K
2024incomplete	1,504	$307K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
J3262	Injection, tocilizumab, 1 mg	80%	731	528	$1.79M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	13%	4,796	4,236	$285K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	5.9%	2,571	1,977	$132K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	<1%	120	120	$19K
99244	Office or other outpatient consultation, moderate to high complexity	<1%	25	24	$4K
36415	Collection of venous blood by venipuncture	<1%	3,359	2,895	$3K
96415		<1%	53	38	$874.24
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	30	13	$677.17
96401		<1%	14	13	$519.59
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	19	13	$50.21

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBROMBERG, REUVEN (MANAGER)